Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132644) titled 'A randomized controlled, open label clinical study of IL-1 inhibitor combined with febuxostat in the treatment of chronic gouty stone arthritis patients' on Sept. 16.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Ustcanhui Provincial Hospital
Condition:
Chronic gouty arthritis
Intervention:
Experimental group:Firsekibart + Febuxostat
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-09-18
Target Sample Size: Experimental group:15;Control group:15;
Countries of Recruitment:
China
To know more, visit https://www.c...